Parthenon LLC Has $497,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Parthenon LLC lessened its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,495 shares of the pharmacy operator’s stock after selling 2,290 shares during the quarter. Parthenon LLC’s holdings in Walgreens Boots Alliance were worth $497,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. New Covenant Trust Company N.A. acquired a new stake in Walgreens Boots Alliance during the 1st quarter worth $35,000. Iron Horse Wealth Management LLC grew its stake in shares of Walgreens Boots Alliance by 162.5% during the second quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after purchasing an additional 1,300 shares during the period. Blue Trust Inc. grew its stake in shares of Walgreens Boots Alliance by 87.0% during the second quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 1,081 shares during the period. Continuum Advisory LLC lifted its stake in Walgreens Boots Alliance by 71.2% in the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock valued at $30,000 after buying an additional 1,020 shares during the period. Finally, Strategic Investment Solutions Inc. IL bought a new position in Walgreens Boots Alliance during the second quarter worth about $34,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Up 2.2 %

Shares of WBA traded up $0.20 during mid-day trading on Wednesday, hitting $9.21. 4,049,871 shares of the company’s stock were exchanged, compared to its average volume of 17,283,682. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. Walgreens Boots Alliance, Inc. has a 52 week low of $8.22 and a 52 week high of $27.05. The company has a market cap of $7.96 billion, a PE ratio of -0.90, a P/E/G ratio of 1.23 and a beta of 0.69. The company has a 50-day simple moving average of $9.18 and a 200 day simple moving average of $12.01.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $37.50 billion for the quarter, compared to analyst estimates of $35.75 billion. During the same period in the previous year, the business earned $0.67 EPS. The company’s revenue was up 5.9% compared to the same quarter last year. On average, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 12th. Shareholders of record on Monday, November 18th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a yield of 10.86%. Walgreens Boots Alliance’s dividend payout ratio is -9.99%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. UBS Group increased their price target on shares of Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research report on Thursday, October 17th. Evercore ISI increased their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a report on Wednesday, October 16th. Bank of America decreased their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a report on Wednesday, September 4th. Barclays raised their price objective on Walgreens Boots Alliance from $7.00 to $8.00 and gave the stock an “underweight” rating in a research note on Wednesday, October 16th. Finally, Morgan Stanley lowered their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a report on Friday, October 11th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.